
|Articles|July 24, 2023
World-Leading CDMO Service
Author(s)SGS
To support the growing need for nitrosamine testing, SGS has expanded its volume for nitrosamine testing beyond its current service offering in Mississauga, Canada. SGS has added capacity and instrumentation to offer nitrosamine testing, including drug substance-related impurities (NDSRIs) at its West Chester, PA and Markham, Canada laboratories to allow for expanded capacity for nitrosamine testing, while staying ahead of the curve as regulations continue to evolve.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Building the Foundations for Proactive Drug Safety in 2026
3
Amgen Acquires UK Biotech Dark Blue Therapeutics
4
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
5